Last reviewed · How we verify
Phlebotonic
At a glance
| Generic name | Phlebotonic |
|---|---|
| Also known as | Aminaftone |
| Sponsor | Italfarmaco |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Multicenter Prospective Real-world Observational Study to Evaluate the Effectiveness of Phlebotonics, as Conservative Therapy in a Cohort of Patients With Symptomatic Hemorrhoidal Disease (HD) of I, II or III Goligher Grade
- The Effect of Rubber Band Ligation in Bleeding Internal Hemorrhoids.
- The Efficacy and Safety of Different Phlebotonic Drugs in Children With Venous Malformations
- Iliac Vein Stenting in Advanced Chronic Venous Insufficiency (PHASE4)
- Calcium Dobesilate for Chronic Venous Wounds (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Phlebotonic CI brief — competitive landscape report
- Phlebotonic updates RSS · CI watch RSS
- Italfarmaco portfolio CI